Background & aims: Eating habits may influence the life span and the quality of ageing process by modulating inflammation. The RISTOMED project was developed to provide a personalized and balanced diet, enriched with or without nutraceutical compounds, to decrease and prevent inflammageing, oxidative stress and gut microbiota alteration in healthy elderly people. This paper focused on the effect on inflammation and metabolism markers after 56 days of RISTOMED diet alone or supplementation with three nutraceutical compounds. Methods: A cohort of 125 healthy elderly subjects was recruited and randomized into 4 arms (Arm A, RISTOMED diet; Arm B, RISTOMED diet plus VSL#3 probiotic blend; Arm C, RISTOMED diet plus AISA dLimonene; Arm D, RISTOMED diet plus Argan oil). Inflammatory and metabolism parameters as well as the ratio between Clostridium cluster IV and Bifidobacteria (CL/B) were collected before and after 56 days of dietary intervention, and their evolution compared among the arms. Moreover, participants were subdivided according to their baseline inflammatory parameters (erythrocytes sedimentation rate (ESR), C-Reactive Protein, fibrinogen, Tumor Necrosis Factor-alfa (TNF-a), and Interleukin 6) in two clusters with low or mediumehigh level of inflammation. The evolution of the measured parameters was then examined separately in each cluster. Results: Overall, RISTOMED diet alone or with each nutraceutical supplementation significantly decreased ESR. RISTOMED diet supplemented with d-Limonene resulted in a decrease in fibrinogen, glucose, insulin levels and HOMA-IR. The most beneficial effects were observed in subjects with a mediumehigh inflammatory status who received RISTOMED diet with AISA d-Limonene supplementation. Moreover, RISTOMED diet associated with VSL#3 probiotic blend induced a decrease in the CL/B ratio.
Introduction
One of the typical aspects of the ageing process is the development of a low grade inflammatory status called "inflammageing" which plays a critical role in the pathogenesis of the main agerelated chronic diseases as Parkinson's and Alzheimer's diseases, type 2 diabetes, atherosclerosis, sarcopenia and cancer [1e3] .
This inflammatory status includes a profound modification within the cytokine network leading to a general increase in plasma levels and cell capability to produce pro-inflammatory cytokines with a subsequent increase of the main inflammatory markers [4] .
Inflammageing is the result of a dynamic signaling produced by different organs and tissues. In particular, adipose tissue has been recognized as an active endocrine organ able to regulate physiological and pathological processes, such as immunity and inflammation, through the production of pro-inflammatory and antiinflammatory factors, including cytokines (Interleukin-6, IL-6 and Tumor Necrosis Factor-alpha, TNF-a), adipokines (leptin, adiponectin and resistin), and chemokines. The aging process is physiologically associated with a lean body mass loss leading to an increase in fat mass percentage on body weight, specifically in the abdominal region [5] . In this context, anti-inflammatory strategies may be useful to prevent or delay ageing and the onset of agerelated diseases [6] .
The excessive intake of energy and nutrients together with the kind of nutrients consumed may turn on inflammatory pathways, directly or indirectly, through different mechanisms such as the induction of obesity and endoplasmic reticulum stress. In particular, dietary fatty acids may affect inflammatory processes notably through modulation of the metabolism of eicosanoids and of the expression of inflammatory cytokines through a series of transcriptional events mediated by NF-kB. Moreover, sugars and carbohydrates stimulate pancreatic islets and insulin-sensitive tissues such as adipose tissue, liver and muscles [7e9] . Conversely, malnutrition and, in particular, a diet with insufficient protein intake, is associated with frailty, decline in functional status, impaired muscle function, decreased bone mass, immune dysfunction, reduced cognition and mortality [9e11] .
For all these reasons, assessment of the adequate dietary requirement and administration of the correct nutritional intake could be a fundamental issue to maintain or restore health in advanced age.
The European project RISTOMED (www.ristomed.eu), a multicenter 'open-label' randomized study (CORDIS FP7), was designed to develop and provide a healthy, personalized and balanced dietary intervention, enriched or not with specific nutraceutical compounds, to decrease and prevent inflammageing, oxidative stress and gut microbiota alteration in healthy elderly people. RISTOMED diet was built to reach the recommended daily requirement of nutrients, vitamins and minerals complying with different cultural patterns. RISTOMED diet was designed with a particular attention towards those foods and nutrients known or suspected to be able to reduce inflammation and oxidative stress by promoting a healthy gut microbiota in elderly people [12] .
The aim of this study was to investigate the effect of RISTOMED diet supplemented or not with nutraceuticals on inflammageing and other critical processes (oxidative stress and gut microbiota alteration) in elderly healthy people, taking into account that the health of gut microbiota is associated with the immune functionality [13] . The primary outcome was the decrease of hsCRP (highsensitivity C-reactive protein) levels in each study arm. HsCRP was selected as primary outcome because it is an internationally recognized marker of inflammation and cardiovascular risk [14, 15] . Secondary outcomes included other markers of inflammatory and metabolic status, oxidative stress, gut microbiota composition as well as quality of life and physical performance.
In the present paper, we report some results of the RISTOMED study, focusing on the effect of RISTOMED diet alone or with three nutraceutical compounds, namely a probiotic blend, an orange peel extract containing d-Limonene and Argan oil, on inflammatory and metabolic markers in healthy elderly subjects.
Materials and methods

Recruitment
It was planned to recruit 144 elderly subjects (age 65e85 years old, equal number of males and females) in three European cities (Rome, Italy; Bordeaux, France; Berlin, Germany), between May 2009 and April 2010, according to strict inclusion and exclusion criteria. Body Mass Index (BMI) was to be in the range of 22e30 kg/ m 2 , in the absence of known diseases (neurologic or psychiatric disorder, geriatric anorexia, active infection, constipation and gastric disease requiring medical therapy, chronic inflammatory bowel disease, diabetes mellitus, dyslipidemia and/or other metabolic diseases, neoplasms). The subjects should not receive any chronic anti-inflammatory therapy such as NSAIDs nor any other kind of therapy in the 20 days before the beginning of the study. Participants had to use no food supplements or functional foods such as probiotics, prebiotics, vitamins and minerals in the week before the beginning of the study. Moreover, the subjects had to be able to comply with management of nutraceutical products, to use a computer and to access the web, by themselves or with the help of a caregiver. The study protocol was approved by the ethics committee at each recruiting institution and the participants gave written informed consent at enrollment. The study was registered at ClinicalTrials.gov as NCT01069445eNCT01179789, and was conducted under the 7th Framework Program of the European Commission. After obtaining informed consent, the subjects were randomized into 4 arms: Arm A received the RISTOMED diet alone, Arm B received the RISTOMED diet supplemented with the VSL#3 probiotic blend, Arm C received the RISTOMED diet supplemented with the AISA-5203-L fruit peel extracted monoterpene d-Limonene, Arm D received the RISTOMED diet supplemented with Argan Oil. Randomization was performed centrally and stratified by recruitment center and gender as described elsewhere [12] . The study was conducted in accordance with International Good Clinical Practice guidelines (ICH, May 1977), the Declaration of Helsinki, and national laws and regulations.
All subjects were evaluated before starting the study (D0) and after a period of 56 ± 2 days of diet with or without supplementation (D56). A fasting venous blood sample and stools were collected early in the morning before (D0) and after the diet period (D56).
Diet
The RISTOMED diet was personalized by a dietician using the RISTOMED-Health dietary Services (www.ristomed.eu) [12] . Each participant received a personal login to the RISTOMED website, and was trained by a dietician to get the personalized diet from the web platform. Recipes and daily menus were formulated taking into account traditional and personal eating habits. The nutritional pattern was established in agreement with the current dietary recommendations for elderly people, specific attention being given to the intake of food compounds that can affect inflammation, oxidative stress and gut microbiota [i.e. Poly Unsaturated Fatty Acids e PUFA n-6/n-3 ratio e antioxidant vitamins (vitamin E, C and carotenoids) and minerals (zinc and selenium), polyphenols and soluble dietary fiber].
The RISTOMED diet provided~15% of energy as proteins, 50e60% as carbohydrates and~35% as lipids. The latter were 15e20% Mono-Unsaturated Fatty Acids (MUFA), provided by virgin olive oil,~8% Saturated Fatty Acids (SFA) and~7% PUFA with 0.5% alinolenic acid and 2% linoleic acid. The daily recommended intake of uncooked Argan oil (25 mL), when required in the study arm, was given in partial replacement of an equal amount of extra-virgin olive oil. Dietary fiber intake was~35 g/day with an insoluble/soluble fiber ratio of around 1:1, related to the prebiotic activity generally assigned to soluble fiber [16] . Polyphenols' intake was established at !400 mg/day (as phenolic acids plus flavonoids; [17] ). The intake of vitamins and minerals was referenced to the WHO program "Keep fit for life" [18] . The minimum water need for elderly people is 1e1.5 mL/kcal/day and it was recommended to use a calcium-rich water (Ca ! 150 mg/L).
On the website, participants recorded their weight weekly and described the compliance to the diet and to the nutraceutical supplementation daily. After 2 and 6 weeks (D14 and D42) from the beginning of the intervention, the nutritionist/dietician contacted by phone each participant to verify his/her compliance to the diet and to the nutraceutical supplementation.
Nutraceutical supplementation
VSL#3 probiotic blend (ACTIAL Farmaceutica Lda) is formulated as a granulated powder of 112 billion lyophilized bacteria per capsule in defined ratios of 4 strains of Lactobacillus (Lactobacillus paracasei, Lactobacillus plantarum, Lactobacillus acidophilus, and Lactobacillus delbrueckii subsp. bulgaricus), 3 strains of Bifidobacterium (Bifidobacterium longum, Bifidobacterium breve, and Bifidobacterium infantis) and Streptococcus thermophilus. The product was administered orally, 2 capsules daily on an empty stomach with a glass of water.
The monoterpene AISA 5203-L (d-Limonene and its metabolites) extracted from orange peel was administrated orally in soft gel capsules with a meal and a large glass of water. The daily number of soft gel capsules was established for each patient according to the recommended dose of 10 ± 1 mg/kg.
Argan oil, the extra-virgin oil obtained using a cold-pressed technique of kernels contained in the Argania spinosa fruit, was 
supplied in 12.5 mL monodose sachets. The daily recommended intake was 25 mL taken as two monodoses per day at each person's convenience with breakfast, lunch and/or dinner.
Laboratory analyses
Peripheral blood analyses were performed on whole blood, serum or plasma collected as described above [12] . Standard clinical laboratory methods or specific ELISA tests were used (Aushon Biosystems, Billerica, MA; BioVendor, Modrice, Czech Republic; Mediagnost, Reutlingen, Germany). Inflammatory status was established using Erythrocytes Sedimentation Rate (ESR), hsCRP, fibrinogen, TNF-a and IL-6. Since changes in the gut microbiota composition may be connected with inflammageing, stool samples were collected on D0 and D56 to measure the ratio between Clostridium cluster IV and Bifidobacteria (CL/B) through 16S rRNA genetargeted qPCR [12] .
Insulin resistance was assessed by measuring glucose and insulin levels and calculating the HOMA-IR index according to a previously published formula [19] .
Statistical analyses
The effects of the dietary interventions measured on D56 were assessed as percentage variations compared to baseline, in order to minimize individual disparities. After testing for normality, these percentages of variation were compared between the four arms with a KruskaleWallis test. Paired Wilcoxon rank sum tests were used to assess the median percentages of variations for each parameter between D0 and D56 according to the arm of dietary intervention. Two-Step Cluster Analysis was applied to determine 2 groups of subjects identified as "low inflammation" and "mediumehigh inflammation" clusters using the inflammatory parameters described above at baseline. As Two-Step Cluster Analysis assumes a normal distribution of interval data the parameters were ztransformed to approximate normality. Baseline comparisons between the two inflammation clusters were performed using a Mann Whitney test. KruskaleWallis and paired Wilcoxon tests were applied as above in each cluster.
All tests were performed using the Medcalc ® (bvba, Ostend, Belgium) software and SPSS/Win program version 19 (Spss Inc., Chicago, IL). The level of statistical significance was defined by a two-tailed p value < 0.05.
Results
Global analysis
A total of 125 elderly subjects (mean age 70.4 ± 3.9 yrs, 58 males and 67 females) were recruited and completed the study. The flow chart of participants is reported in Fig. 1 , drop outs for each arm are reported in Table 1 . No significant differences in age (p ¼ 0.550) and gender distribution (p ¼ 0.568) were found between the three recruitment centers (data not shown). As shown in Table 2 , the four arms of dietary intervention were comparable in age, gender distribution and BMI at baseline (D0). Compliance with the intake of nutraceuticals was between 87% and 95%, between 71% and 80% and between 81% and 90% for VSL#3, AISA, and Argan Oil respectively in different centers.
The differences between D0 and D56 were compared among the four arms of dietary intervention.
Although this was the primary outcome expected, hsCRP variations were not significant either between arms or within each of them (Arm A, median variation À7.7%, Arm B, 0%, Arm C, À7.1% and Arm D, 0%, KruskaleWallis test p ¼ 0.86). 
Statistical analyses were performed by KruskaleWallis test; *p < 0.05 between arm C and arms A and D. (Table 3) .
Analysis according to the inflammation status at baseline
As mentioned above, two-step cluster analysis based on available inflammatory parameters (ESR, hsCRP, fibrinogen, TNF-a and IL-6) at baseline (D0) identified two clusters of older subjects with low or mediumehigh level of inflammation (Table 4 ). The "low inflammation" cluster consisted of 51 subjects (mean age 69.5 ± 3.76 yrs, 23 males and 28 females). The "mediumehigh inflammation" cluster consisted of 69 subjects (mean age 70.9 ± 3.93 yrs, 27 males and 42 females). Inflammatory parameters (except TNF-a) were significantly higher in subjects belonging to the mediumehigh inflammation cluster compared to subjects in the low inflammation cluster ( Table 5) .
The effects on dietary interventions were then analyzed according to the inflammation status of the subjects in each arm of dietary intervention.
In the low inflammation cluster, minor response to the dietary interventions was seen. The only significant change, comparing the four arms by KruskaleWallis analysis, was increased fibrinogen levels in Arm D (þ29.9% compared to all other groups, p ¼ 0.03). The percentage of variation between D0 and D56 was indeed highly significant in this group (paired Wilcoxon test, p ¼ 0.007). No significant changes in fibrinogen levels were seen in the other arms. Within arms analyses by paired Wilcoxon tests further showed that ESR significantly decreased in Arm A (À37; 6%, p ¼ 0.03), and that glucose decreased in Arm C (À6.3%, p ¼ 0.005, data not shown).
In the mediumehigh inflammation cluster, the percentages of variation between D0 and D56, tested between arms by a KruskaleWallis test, showed that the CL/B ratio (p ¼ 0.03) and IL-6 levels (p ¼ 0.04) were significantly different (Fig. 4) . Indeed, the CL/B ratio was significantly decreased in Arm B (À46.2%) compared to Arms C (þ95.5%) and D (þ83.2%) and IL-6 levels were significantly decreased in Arm C (À26.3%) compared to Arms A (þ17.3%) and B (þ15.9%).
Within arms analyses by paired Wilcoxon tests further showed that ESR decreased significantly in Arm B (À27%, p ¼ 0.049) and in Arm D (À49%, p ¼ 0.009) while the CL/B ratio increased significantly in Arm D (þ83%, p ¼ 0.008) and C (þ95.5%, p ¼ 0.04, data not shown). By contrast, inflammatory markers (fibrinogen p ¼ 0.015; IL-6, p ¼ 0.009) and insulin resistance parameters (insulin, p ¼ 0.05; HOMA-IR, p ¼ 0.048) significantly decreased in Arm C (Fig. 5 ).
Discussion
Observational studies have examined the association of the Mediterranean diet with inflammatory markers in healthy adults, reporting that this dietary regimen is able to reduce the expression of pro-inflammatory and proatherogenic genes in elderly people [20e22] .
The innovative aspect of the European study RISTOMED was to design diets combining traditional foods and recipes with nutraceutical compounds allowing to assess their effectiveness in the context of a personalized balanced Mediterranean diet, the RIS-TOMED diet.
Here we show that RISTOMED diet and nutraceutical supplementation can significantly modulate inflammation and insulin resistance parameters, especially in healthy older people with a medium/high inflammatory status. Indeed, there is evidence in the literature that glucose metabolism and the inflammatory status are closely related [23] . Of note, among inflammation related parameters, we also considered gut microbiota modifications induced by dietary interventions and supplementation tested.
The anti-inflammatory effect of the RISTOMED diet, with or without supplementation, translated in a significant decrease of ESR in all arms. This parameter is a nonspecific indicator of infection and tissue injury often used to monitor chronic inflammation and response to treatment in inflammatory diseases [24] . However, we did not find changes in hsCRP levels after the dietary interventions. A recent paper showed that CRP and the proteins that contribute to the ESR, such as fibrinogen, alpha-2 macroglobulin and immunoglobulins have distinct time courses and kinetics. Thus, CRP can rise and then fall at a different rate than ESR explaining the disagreements between these measures [25] . RISTOMED diet supplemented with natural d-Limonene extracted from orange peel decreased significantly fibrinogen levels. Of interest, this dietary and nutraceutical intervention affected significantly the largest number of parameters, with a major impact on insulin resistance markers.
When the subjects were further subdivided according to their baseline inflammatory profile, it is notable that only very few parameters were modified by the RISTOMED diet, stressing the inability to show an improvement in healthy not inflamed old individuals, using the inflammatory biomarkers selected in the RIS-TOMED study. Conversely, for subjects presenting a clear "inflammageing" profile, RISTOMED diet supplemented with dLimonene significantly impacted on both inflammation and insulin resistance markers.
This study interestingly included investigation of variations of the microbiome concentrating on Clostridium cluster IV and Bifidobacteria spp. In a previous paper, it was shown that RISTOMED diet supplemented with VSL#3 probiotic blend increased Bifidobacteria and supported adequate folate and vitamin B12 concentrations decreasing homocysteine levels and suggesting a protective role for aging associated conditions, e.g. cardiovascular or neurodegenerative diseases [12] . Here we confirmed that the RISTOMED diet associated with VSL#3 probiotic blend induced a decrease of the ratio between Clostridium cluster IV and Bifidobacteria, suggesting a better survival of Bifidobacteria spp. Conversely, the ratio showed a trend for increase in the other arms. When subdividing the subjects according to their baseline inflammatory status, striking differences were noted. RISTOMED diet supplemented with VSL#3 probiotic blend tended to increase the ratio between Clostridium cluster IV and Bifidobacteria in the "low inflammation group" and to lower it in the "mediumehigh inflammation" group, while RISTOMED diet supplemented with dLimonene had the reverse effect. These variations could be explained by the different targets of probiotics, acting directly on the intestinal microbiome, and d-Limonene, modifying the intestinal barrier function as reported elsewhere [26] .
In conclusion, in spite of the relatively small size of the subgroups and dispersion of data, non-parametric analysis allowed to demonstrate that a balanced Mediterranean dietary regimen can counteract inflammageing, especially in elderly individuals with already altered inflammation parameters, on a prevention perspective. A screening in search of such latent inflammation might guide towards the most appropriate personalized approach. It moreover suggests that d-Limonene supplementation in the context of this dietary intervention could have a beneficial effect on older people in limiting the negative influence of chronic inflammation as demonstrated in other models [27] and improving insulin resistance parameters.
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